In the present paper, we have performed an association study to assess whether TRAF3IP2 variants could also contribute to the susceptibility to Nevirapine-induced SJS/TEN in a Mozambican population. The gene discussed is TRAF3IP2; the disease is Schwartz-Jampel syndrome.